https://www.selleckchem.com/pr....oducts/talabostat.ht
These results provide evidence and molecular substrates for the pharmacological development of ATM inhibition in autism spectrum disorders.The emergence of drug-resistant fungi has prompted an urgent threat alert from the US Centers for Disease Control (CDC). Biofilm assembly by these pathogens further impairs effective therapy. We recently identified an antifungal, turbinmicin, that inhibits the fungal vesicle-mediated trafficking pathway and demonstrates broad-spectrum activity against planktonically growing fungi. During biofilm g
Like
Comment
Share
